"Patient Advocacy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Promotion and protection of the rights of patients, frequently through a legal process.
| Descriptor ID |
D010344
|
| MeSH Number(s) |
I01.880.604.631 N03.706.678
|
| Concept/Terms |
Patient Ombudsmen- Patient Ombudsmen
- Ombudsmen, Patient
- Patient Ombudsman
- Ombudsman, Patient
Patient Representatives- Patient Representatives
- Patient Representative
- Representative, Patient
- Representatives, Patient
|
Below are MeSH descriptors whose meaning is more general than "Patient Advocacy".
Below are MeSH descriptors whose meaning is more specific than "Patient Advocacy".
This graph shows the total number of publications written about "Patient Advocacy" by people in this website by year, and whether "Patient Advocacy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 2 | 4 |
| 1997 | 1 | 1 | 2 |
| 1998 | 1 | 3 | 4 |
| 1999 | 0 | 1 | 1 |
| 2001 | 1 | 2 | 3 |
| 2002 | 1 | 1 | 2 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 2 | 3 |
| 2012 | 2 | 1 | 3 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 3 | 2 | 5 |
| 2016 | 2 | 1 | 3 |
| 2017 | 1 | 2 | 3 |
| 2019 | 1 | 4 | 5 |
| 2020 | 1 | 1 | 2 |
| 2021 | 1 | 2 | 3 |
| 2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Patient Advocacy" by people in Profiles.
-
A Media Advocacy Toolkit for the Allergist-Immunologist. J Allergy Clin Immunol Pract. 2024 Oct; 12(10):2678-2686.
-
FIGIJ and NASPAG Advocacy Statement Supporting Fertility Preservation for Pediatric and Adolescent Patients Receiving Gonadotoxic Therapy. J Pediatr Adolesc Gynecol. 2024 Oct; 37(5):457-459.
-
Persistent under-representation of female patients in United States trials of common vascular diseases from 2008 to 2020. J Vasc Surg. 2022 01; 75(1):30-36.
-
The Impact of Political Advocacy on the Plastic Surgeon: A Data-Driven Analysis. Plast Reconstr Surg. 2021 Jun 01; 147(6):1039-1049.
-
Barriers and Facilitators to Adolescent and Young Adult Cancer Trial Enrollment: NCORP Site Perspectives. JNCI Cancer Spectr. 2021 06; 5(3).
-
Professionally responsible advocacy for women and children first during the COVID-19 pandemic: guidance from World Association of Perinatal Medicine and International Academy of Perinatal Medicine. J Perinat Med. 2020 Nov 26; 48(9):867-873.
-
Multidisciplinary considerations in the treatment of triple-negative breast cancer. CA Cancer J Clin. 2020 11; 70(6):432-442.
-
Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer. JAMA Oncol. 2019 12 01; 5(12):1790-1798.
-
Factors influencing implementation of a computerized, individualized, culturally tailored lupus decision aid in lupus clinics: a qualitative semi-structured interview study. Clin Rheumatol. 2019 Oct; 38(10):2793-2801.
-
Social media and Essure hysteroscopic sterilization: a perfect storm. Fertil Steril. 2019 06; 111(6):1105-1106.